Precision BioSciences, Inc. (DTIL)
9.87
+1.75
(+21.55%)
USD |
NASDAQ |
Nov 05, 16:00
9.80
-0.07
(-0.71%)
After-Hours: 07:48
Precision BioSciences EPS Diluted (Quarterly) : -0.2765 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.2765 |
| June 30, 2026 | -1.263 |
| March 31, 2026 | -0.7486 |
| December 31, 2025 | 1.004 |
| September 30, 2025 | -1.842 |
| June 30, 2025 | -2.129 |
| March 31, 2025 | -2.213 |
| December 31, 2024 | -2.218 |
| September 30, 2024 | -2.254 |
| June 30, 2024 | 4.671 |
| March 31, 2024 | 1.696 |
| December 31, 2023 | -4.062 |
| September 30, 2023 | -4.304 |
| June 30, 2023 | -94.37 |
| March 31, 2023 | -6.755 |
| December 31, 2022 | -7.702 |
| September 30, 2022 | -6.481 |
| Date | Value |
|---|---|
| June 30, 2022 | -13.70 |
| March 31, 2022 | -13.85 |
| December 31, 2021 | -10.98 |
| September 30, 2021 | -5.672 |
| June 30, 2021 | 10.86 |
| March 31, 2021 | -9.902 |
| December 31, 2020 | -13.36 |
| September 30, 2020 | -14.91 |
| June 30, 2020 | -18.90 |
| March 31, 2020 | -15.69 |
| December 31, 2019 | -12.27 |
| September 30, 2019 | -12.29 |
| June 30, 2019 | -11.65 |
| March 31, 2019 | -18.93 |
| December 31, 2018 | -9.226 |
| March 31, 2018 | -5.384 |
| December 31, 2017 | -4.410 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 7.077 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.1417 |
| Imunon, Inc. | -0.5412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.586M |
| Total Expenses (Quarterly) | 7.586M |
| Enterprise Value | 221.18M |
| Earnings Yield | -13.01% |
| Normalized Earnings Yield | -13.87 |